Low-dose rituximab for the treatment of acute thrombotic thrombocytopenic purpura: Report of four cases

Author： Peque駉-Lu関ano Myrna Villarreal-Mart韓ez Laura Jaime-P閞ez Jos?Carlos G髆ez-de-Le髇 Andr閟 Cant?Rodr韌uez Olga Graciela Gonz醠ez-Llano Oscar G髆ez-Almaguer David

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.18, Iss.4, 2013-07, pp. : 233-236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should low-dose mycophenolate mofetil be used to prolong the response after rituximab therapy in patients with immune thrombocytopenic purpura? A case report

By Bruserud Øyvind Håvardstein Kathrine

Hematology, Vol. 14, Iss. 4, 2009-08 ,pp. : 224-226

Maney Publishing

Access to resources Recommend Favorite

Rituximab Therapy for Refractory Thrombotic Thrombocytopenic Purpura

By Gutterman L.A. Kloster B. Tsai H-M.

Blood Cells, Molecules, and Diseases, Vol. 28, Iss. 3, 2002-03 ,pp. : 385-391

Academic Press

Access to resources Recommend Favorite

Vincristine as treatment for recurrent episodes of thrombotic thrombocytopenic purpura

By Ferrara F. Annunziata M. Pollio F. Palmieri S. Copia C. Mele G. Pocali B. Schiavone E.

Annals of Hematology, Vol. 81, Iss. 1, 2002-01 ,pp. : 7-10

Springer Publishing Company

Access to resources Recommend Favorite

Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab

By Chemnitz Jens Uener Jens Hallek Michael Scheid Christof

Annals of Hematology, Vol. 89, Iss. 10, 2010-10 ,pp. : 1029-1033

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP)

By Alasfoor Kholood

Annals of Hematology, Vol. 88, Iss. 3, 2009-03 ,pp. : 239-243

Springer Publishing Company

Access to resources Recommend Favorite